The present invention discloses novel pharmaceutical cocrystals of Temozolomide specifically with mono and di carboxylic acids selected from oxalic acid, succinic acid, salicylic acid in a fixed stoichiometry for improved hydrolytic stability compared to the pure drug. The organic carboxylic acids in pKa range 2-6 are used as pH adjusters in cocrystals.
展开▼
